Correlates between models of virulence for Mycobacterium tuberculosis among isolates of the Central Asian lineage: a case for lysozyme resistance testing?

Infection and Immunity
Claire PardieuFrancis Drobniewski

Abstract

Virulence factors (VFs) contribute to the emergence of new human Mycobacterium tuberculosis strains, are lineage dependent, and are relevant to the development of M. tuberculosis drugs/vaccines. VFs were sought within M. tuberculosis lineage 3, which has the Central Asian (CAS) spoligotype. Three isolates were selected from clusters previously identified as dominant in London, United Kingdom. Strain-associated virulence was studied in guinea pig, monocyte-derived macrophage, and lysozyme resistance assays. Whole-genome sequencing, single nucleotide polymorphism (SNP) analysis, and a literature review contributed to the identification of SNPs of interest. The animal model revealed borderline differences in strain-associated pathogenicity. Ex vivo, isolate C72 exhibited statistically significant differences in intracellular growth relative to C6 and C14. SNP candidates inducing lower fitness levels included 123 unique nonsynonymous SNPs, including three located in genes (lysX, caeA, and ponA2) previously identified as VFs in the laboratory-adapted reference strain H37Rv and shown to confer lysozyme resistance. C72 growth was most affected by lysozyme in vitro. A BLAST search revealed that all three SNPs of interest (C35F, P76Q, a...Continue Reading

References

Nov 1, 1991·British Journal of Industrial Medicine·T SandströmN Stjernberg
Sep 1, 1969·The Journal of Hygiene·H A Druett
Aug 30, 2001·Journal of Clinical Microbiology·A KrüünerG Källenius
Feb 16, 2002·The Science of the Total Environment·Rudolf E Noble
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·R BroschS T Cole
Mar 20, 2002·The Journal of Clinical Investigation·Tomas Ganz
Mar 27, 2003·Molecular Microbiology·Christopher M SassettiEric J Rubin
Oct 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christopher M Sassetti, Eric J Rubin
Mar 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Aaron E HirshPeter M Small
Mar 30, 2004·Thorax·M C RuddyH Maguire
Oct 23, 2004·Emerging Infectious Diseases·Lucy BakerFrancis Drobniewski
Mar 16, 2005·The Lancet Infectious Diseases·Aeesha N J Malik, Peter Godfrey-Faussett
Jun 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jyothi RengarajanEric J Rubin
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sebastien GagneuxPeter M Small
Oct 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sandra M NewtonRobert J Wilkinson
Apr 24, 2007·The Lancet Infectious Diseases·Sebastien Gagneux, Peter M Small
Jun 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Diane OrdwayIan M Orme
Jan 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jyothi RengarajanEric J Rubin
Jun 3, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Mark P Nicol, Robert J Wilkinson
Aug 16, 2008·The Journal of Infectious Diseases·Bouke C de JongRichard A Adegbola
May 26, 2009·Journal of Bacteriology·Omar H VandalSabine Ehrt
Feb 2, 2010·Emerging Infectious Diseases·Timothy BrownFrancis Drobniewski
Aug 4, 2010·Emerging Infectious Diseases·Kathleen A AlexanderNicolaas C Gey van Pittius
Mar 16, 2011·Infection and Immunity·Tania Di PietrantonioErwin Schurr
Aug 13, 2011·Tuberculosis·M HanekomR M Warren

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

© 2021 Meta ULC. All rights reserved